Catalent | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Agilent USD 454M 44M 2025-04
AstraZeneca USD 3.59B 1.96B 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Bruker USD 225.4M 21.9M 2025-03
Centene USD 3.35B 129M 2025-03
Charles River Laboratories USD 177.8M 10.46M 2025-03
Cigna USD 4B 230M 2025-03
Danaher USD 1.86B 165M 2025-03
Dentsply International USD 357M 18M 2025-03
Elevance Health USD 10.74B 376M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Hologic USD 266.4M 1.4M 2025-03
Humana 3.97B 631M 2024-12
Illumina USD 247M 16M 2025-03
Intuitive Surgical USD 563.4M 49.2M 2025-03
IQVIA Holdings USD 508M 55M 2025-03
J&J USD 5.11B 1.34B 2025-03
Laboratory Of America USD 546M 49.2M 2025-03
McKesson USD 1.97B 54M 2025-03
Merck EUR 1.47B 418M 2025-03
Merck USD 2.53B 319M 2025-03
Mettler Toledo International USD 242.8M 5.46M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Quest Diagnostics USD 476M 10M 2025-03
Repligen USD 71.26M 10.93M 2025-03
Revvity USD 249.72M 5.9M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Thermo Fisher Scientific USD 1.72B 487M 2025-03
UnitedHealth USD 13.59B 1.1B 2025-03
Waters USD 174.88M 1.61M 2025-03
West Pharmaceutical Services USD 88M 2.7M 2025-03



Catalent Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.